Google News • 1/12/2026 – 1/14/2026
AbbVie has reached an agreement with the Trump administration to improve access and affordability for Americans regarding certain drugs. In exchange for tariff relief, AbbVie has pledged a $100 billion investment in U.S. research and development.
Advertisement
Stories gain Lindy status through source reputation, network consensus, and time survival.



